NASDAQ:IMRX | Profit Breakdown | Immuneering Corp

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$19M-$17.27M
2026-03-31-$15.34M-$13.46M
2025-12-31-$13.75M-$11.58M
2025-09-30-$15.38M-$14.96M
2025-06-30-$14.76M-$14.43M
2025-03-31-$15.48M-$15.05M
2024-12-31-$18.56M-$18.05M
2024-09-30-$15.27M-$14.6M
2024-06-30-$14.91M-$14.08M
2024-03-31-$15.33M-$14.31M
2023-12-31$0.00$0.00-$16.3M-$15.08M
2023-09-30$0.00$0.00-$13.93M-$12.6M
2023-06-30$0.00$0.00-$13.5M-$12.19M
2023-03-31$0.00$0.00-$14.68M-$13.6M
2022-12-31$455.00$455.00-$13.99M-$13.25M
2022-09-30$38,380.00$19,037.00-$13.19M-$12.84M
2022-06-30$94,419.00$46,486.00-$11.65M-$11.53M
2022-03-31$183,698.00$92,852.00-$12.93M-$12.9M
2021-12-31$189,591.00-$16,630.00-$11.12M-$10.78M
2021-09-30$482,130.00$263,042.00-$8.54M-$8.53M
2021-06-30$660,040.00$341,439.00-$7.99M-$7.99M
2021-03-31$748,200.00$339,037.00-$6.24M-$6.23M
2020-12-31$665,080.00$191,847.00-$5.84M-$5.84M
2020-09-30$682,570.00$367,568.00-$4.4M-$4.4M
2020-06-30$480,835.00$243,773.00-$3.61M-$3.6M
2020-03-31-$3.2M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$59.38M-$56.02M
2024-12-31-$64.07M-$61.04M
2023-12-31$0.00$0.00-$58.41M-$53.47M
2022-12-31$316,952.00$158,830.00-$51.74M-$50.51M-$50.51M
2021-12-31$2.08M$926,888.00-$33.89M-$33.84M-$33.54M
2020-12-31$2.31M$1.03M-$17.08M-$17.04M-$17.04M